Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Dec 24, 2021 3:13pm

216 Views

Post# 34261522

Still waiting for 2020 to be the breakout year !

Twitter it must be true , I call BS . Undisclosed amounts to Intelgenx from Tetra , who is in a lawsuit with Tilray early Dec. over their drug product patents. Good Luck , Tetra gave money to another money loosing venture.
Tilray and Aphria who are now one will crush them, funny thing is this information should have been on Twitter since it is real news not just hype and noise. Tilray announced it is going to start making the drug in a film disolving format.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"